MFDS — authorised 31 May 2002
- Marketing authorisation holder: IMCOR PHARMS CO
- Status: likely_approved
🇰🇷 Dimyristoyllecithin in South Korea
MFDS authorised Dimyristoyllecithin on 31 May 2002
Marketing authorisation
Dimyristoyllecithin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Dimyristoyllecithin approved in South Korea?
Yes. MFDS authorised it on 31 May 2002.
Who is the marketing authorisation holder for Dimyristoyllecithin in South Korea?
IMCOR PHARMS CO holds the South Korean marketing authorisation.